Eli Lilly (LLY)
$145.73 0.49 (0.34%)
19:44 EDT LLY Stock Quote Delayed 20 Minutes
Previous Close $145.73
Market Cap 158.18B
PE Ratio 136.20
Volume (Avg. Vol.) 4.42M
Day's Range 143.55 - 146.40
52-Week Range 101.36 - 147.87
Dividend & Yield 2.25 (1.55%)
LLY Stock Predictions, Articles, and Eli Lilly News
- From InvestorPlace
- From the Web
In the latest Eli Lilly news, LLY stock fell more than 2% as the company's late-stage trial of a sarcoma study failed to meet its goals.
Pharmaceutical stocks have been on the rebound and many are raising their prices this year. What does that mean for business?
Roku soared, while the S&P 500, Twilio, Eli Lilly and Nvidia all perked up as well. Here are a few must-see stock charts for Tuesday.
Loxo Oncology (LOXO) stock was flying high on Monday following news of an $8-billion deal between it and Eli Lilly (LLY).
LLY stock is worth a look after Eli Lilly claims its new drugs may provide 45% of 2019 revenue and it can afford to raise its dividend 15%.
These seven stocks are resisting widespread market volatility and will help investors with surviving a bear market. Here's what you need to know about each.
The healthcare sector remains firm even as bears ravage the market. Here are three healthcare stocks to consider during the downturn.
Trump and House Democrats look poised to make deals that will hurt these stocks to sell. Here's what investors need to know.
Earnings set to the tone for Toyota, CVS Health, Eli Lilly and Mylan as our top stock trades. But midterms will set the tone for the week.
Bears have emerged from hibernation. But not all stocks are suffering their wrath. Here are three healthcare stocks to buy.
The stock charts of LLY, M and PPL have earned a second look before the trading week comes to a close.
We are opening a new bullish trade on Eli Lilly (NYSE:LLY), the $106 billion manufacturer of pharmaceutical products. LLY skyrocketed higher after its last earnings announcement, in which the company not only beat revenue and earnings expectations but also announced it would be spinning out part of its Elanco Animal Health division in an initial public offering (IPO).
The stock charts of LLY, HPE and FMC are shaping up as your top trading prospects on this week's hump-day.
BIIB stock jumped on Friday, and for good reason. It's not a buy at these lofty levels, but Biogen has at least earned a spot on your watchlist.
ARMO Biosciences (ARMO) stock is skyrocketing today on news of a massive $1.60 billion deal that will have Eli Lilly (LLY) acquiring it.
Fundamentally PFE is too cheap. So go long on this earnings dip inside a nervous market. Management is proven for decades and is bankable for the future.
LLY stock delivered outstanding results for its just released Q1 report, but significant questions about its future direction remain.
The outlook for the upcoming first-quarter results looks bright. Compare Brokers....
Navellier RatingsPowered by Portfolio Grader